PPARG anticorps (C-Term)
Aperçu rapide pour PPARG anticorps (C-Term) (ABIN4368897)
Antigène
Voir toutes PPARG AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 254-478, C-Term
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
-
Stock
- -20 °C
-
-
- PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
-
Autre désignation
- PPAR gamma
-
Sujet
- Synonyms: peroxisome proliferator-activated receptor gamma , PPAR gamma , PPAR-gamma , nuclear receptor subfamily 1 group C member 3 , peroxisome proliferator-activated receptor gamma 1 , peroxisome proliferator-activated nuclear receptor gamma variant
-
Pathways
- Signalisation MAPK, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Antigène
-